Document:

Exhibit 10.2

 

SECURITIES PURCHASE AGREEMENT

 

This
SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of January 27, 2017, is entered into by and
between ARKADOS GROUP, INC.,
a Delaware corporation, (the “Company”), and LUCAS HOPPEL
(the “Buyer”).

 

A.           The
Company and the Buyer are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded
by the rules and regulations as promulgated by the United States Securities and Exchange Commission (the “SEC”)
under the Securities Act of 1933, as amended (the “1933 Act”).

 

B.           Upon
the terms and conditions stated in this Agreement, the Buyer desires to purchase and the Company desires to issue and sell, upon
the terms and conditions set forth in this Agreement (i) a Convertible Promissory Note of the Company, in the form attached hereto
as Exhibit A (the “Note”), in the original principal amount of $38,500.00 (the “Original
Principal Amount”) (together with any note(s) issued in replacement thereof or as a dividend thereon or otherwise with
respect thereto in accordance with the terms thereof, the “Note”) and (ii) twenty thousand (20,000) restricted
common shares in the Company (“Inducement Shares”) to be delivered to Holder, via overnight courier, within
7 (seven) calendar days following the Closing Date. On the sixth month anniversary of this note, in the event the Companies shares
price has declined the Company agrees to issue the Buyer additional shares such that the aggregate value of the Inducement Shares
equal the aggregate value of the Inducement Shares as of the closing date.

 

NOW THEREFORE, the Company
and the Buyer hereby agree as follows:

 

1.          Purchase
and Sale. On the Closing Date (as defined below), the Company shall issue and sell to the Buyer and the Buyer agrees to purchase
from the Company (i) the Note in the original principal amount of $38,500, and (ii) the Inducement Shares.

 

1.1.          Form
of Payment. On the Closing Date, (i) the Buyer shall pay the purchase price of $35,000 (the “Purchase Price”)
for the Securities to be issued and sold to it at the Closing (as defined below) by wire transfer of immediately available funds
to a Company account designated by the Company, in accordance with the Company’s written wiring instructions, against delivery
of the Securities, and (ii) the Company shall deliver such duly executed Securities on behalf of the Company, to the Buyer, against
delivery of such Purchase Price.

 

1.2.          Closing
Date. The date and time of the issuance and sale of the Securities pursuant to this Agreement (the “Closing Date”)
shall be on or about January 27, 2017, or such other mutually agreed upon time. The closing of the transactions contemplated by
this Agreement (the “Closing”) shall occur on the Closing Date at such location as may be agreed to by the parties.

 

1.3.          Share
Reservation. The Company shall at all times require its transfer agent to establish a reserve of shares of its authorized but
unissued and unreserved Common Stock in the amount of 1,000,000 shares for purposes of exercise of the Warrant or conversion of
the Note. The Company shall cause the Transfer Agent to agree that it will not reduce the reserve under any circumstances, unless
such reduction is pre-approved in writing by the Buyer.

 

     

     

    

 

2.          Buyer’s
Investment Representations; Governing Law; Miscellaneous.

 

2.1         Buyer’s
Investment Representations.

 

(a)          This
Agreement is made in reliance upon the Buyer’s representation to the Company, which by its acceptance hereof Buyer hereby
confirms, that the Securities to be received by it will be acquired for investment for its own account, not as a nominee or agent,
and not with a view to the sale or distribution of any part thereof, and that it has no present intention of selling, granting
participation in, or otherwise distributing the same, but subject nevertheless to any requirement of law that the disposition of
its property shall at all times be within its control.

 

(b)          The
Buyer understands that the Securities are not registered under the 1933 Act, on the basis that the sale provided for in this Agreement
and the issuance of securities hereunder is exempt from registration under the 1933 Act pursuant to Section 4(a)(2) thereof, and
that the Company’s reliance on such exemption is predicated on the Buyer’s representations set forth herein. The Buyer
realizes that the basis for the exemption may not be present if, notwithstanding such representations, the Buyer has in mind merely
acquiring shares of the Securities for a fixed or determinable period in the future, or for a market rise, or for sale if the market
does not rise. The Buyer does not have any such intention.

 

(c)          The
Buyer understands that the Securities may not be sold, transferred, or otherwise disposed of without registration under the 1933
Act or an exemption therefrom, and that in the absence of an effective registration statement covering the Securities or an available
exemption from registration under the 1933 Act, the Stock must be held indefinitely. In particular, the Buyer is aware that the
Securities may not be sold pursuant to Rule 144 or Rule 701 promulgated under the 1933 Act unless all of the conditions of the
applicable Rules are met. Among the conditions for use of Rule 144 is the availability of current information to the public about
the Company. Such information is not now available, and the Company has no present plans to make such information available. The
Buyer represents that, in the absence of an effective registration statement covering the Securities, it will sell, transfer, or
otherwise dispose of the Securities only in a manner consistent with its representations set forth herein and then only in accordance
with the provisions of Section 5(d) hereof.

 

(d)          The
Buyer agrees that in no event will it make a transfer or disposition of any of the Securities (other than pursuant to an effective
registration statement under the 1933 Act), unless and until (i) the Buyer shall have notified the Company of the proposed disposition
and shall have furnished the Company with a statement of the circumstances surrounding the disposition, and (ii) if requested by
the Company, at the expense of the Buyer or transferee, the Buyer shall have furnished to the Company either (A) an opinion of
counsel, reasonably satisfactory to the Company, to the effect that such transfer may be made without registration under the 1933
Act or (B) a “no action” letter from the Securities and Exchange Commission to the effect that the transfer of such
securities without registration will not result in a recommendation by the staff of the Securities and Exchange Commission that
action be taken with respect thereto. The Company will not require such a legal opinion or “no action” letter in any
transaction in compliance with Rule 144.

 

(e)          The
Buyer represents and warrants to the Company that it is an “accredited investor” within the meaning of Securities and
Exchange Commission Rule 501 of Regulation D, as presently in effect and, for the purpose of Section 25102(f) of the California
Corporations Code, he or she is excluded from the count of “purchasers” pursuant to Rule 260.102.13 thereunder.

 

    	 	2	 

     

    

 

2.2           Governing
Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Nevada without regard
to principles of conflicts of laws. Any action brought by either party against the other concerning the transactions
contemplated by this Agreement shall be brought only in the state courts of New York or in the federal courts located in New
York, New York. The parties to this Agreement hereby irrevocably waive any objection to jurisdiction and venue of any action
instituted hereunder and shall not assert any defense based on lack of jurisdiction or venue or based upon forum non
conveniens. In the event that any provision of this Agreement or any other agreement delivered in connection herewith is
invalid or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the
extent that it may conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any such
provision which may prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other
provision of any agreement. Each party hereby irrevocably waives personal service of process and consents to process being
served in any suit, action or proceeding in connection with this Agreement or any other Transaction Document by mailing a
copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address
in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of
process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
other manner permitted by law. THE COMPANY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A
JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS AGREEMENT OR ANY
TRANSACTION CONTEMPLATED HEREBY.

 

2.3           Counterparts.
This Agreement may be executed in one or more counterparts, each of which shall be deemed an original but all of which shall constitute
one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other
party.

 

2.4           Headings.
The headings of this Agreement are for convenience of reference only and shall not form part of, or affect the interpretation of,
this Agreement.

 

2.5           Severability.
In the event that any provision of this Agreement is invalid or unenforceable under any applicable statute or rule of law, then
such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform
with such statute or rule of law. Any provision hereof which may prove invalid or unenforceable under any law shall not affect
the validity or enforceability of any other provision hereof.

 

2.6           Entire
Agreement; Amendments. This Agreement and the instruments referenced herein contain the entire understanding of the parties
with respect to the matters covered herein and therein and, except as specifically set forth herein or therein, neither the Company
nor the Buyer makes any representation, warranty, covenant or undertaking with respect to such matters. No provision of this Agreement
may be waived or amended other than by an instrument in writing signed by the Buyer.

 

2.7           Notices.
Any notice required or permitted hereunder shall be given in writing (unless otherwise specified herein) and shall be deemed effectively
given on the earliest of:

 

2.7.1      the date
delivered, if delivered by personal delivery as against written receipt therefor or by e-mail to an executive officer, or by confirmed
facsimile,

 

2.7.2      the fifth
Trading Day after deposit, postage prepaid, in the United States Postal Service by registered or certified mail, or

 

2.7.3      the third Trading Day after mailing by domestic or international express courier, with delivery costs and fees prepaid, in each
case, addressed to each of the other parties thereunto entitled at the following addresses (or at such other addresses as such
party may designate by ten (10) calendar days’ advance written notice similarly given to each of the other parties hereto):

 

    	 	3	 

     

    

 

	If to the Company, to: 	 
	 	 	 
	 	Arkados Group, Inc.	 
	 	 	 
	 	 	 
	 	 	 

 

	If to the Buyer:	 
	 	 	 
	 	Lucas Hoppel	 
	 	295 Palmas Inn Way	 
	 	Ste 104 PMB 346	 
	 	Humacao, PR 00791	 
	 	Phone: 619-436-4924	 
	 	Email: Luke@LukeHoppel.com	 

 

2.8           Successors
and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and assigns.
Notwithstanding anything to the contrary herein, the rights, interests or obligations of the Company hereunder may not be assigned,
by operation of law or otherwise, in whole or in part, by the Company without the prior written consent of the Buyer, which consent
may be withheld at the sole discretion of the Buyer; provided, however, that in the case of a merger, sale of substantially
all of the Company’s assets or other corporate reorganization, the Buyer shall not unreasonably withhold, condition or delay
such consent. This Agreement or any of the severable rights and obligations inuring to the benefit of or to be performed by Buyer
hereunder may be assigned by Buyer to a third party, including its financing sources, in whole or in part, without the need to
obtain the Company’s consent thereto.

 

2.9           Third
Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective permitted successors
and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other person.

 

2.10         Survival.
The representations and warranties of the Company and the agreements and covenants set forth in this Agreement shall survive the
Closing hereunder notwithstanding any due diligence investigation conducted by or on behalf of the Buyer. The Company agrees to
indemnify and hold harmless the Buyer and all its officers, directors, employees, attorneys, and agents for loss or damage arising
as a result of or related to any breach or alleged breach by the Company of any of its representations, warranties and covenants
set forth in this Agreement or any of its covenants and obligations under this Agreement, including advancement of expenses as
they are incurred.

 

2.11         No
Strict Construction. The language used in this Agreement will be deemed to be the language chosen by the parties to express
their mutual intent, and no rules of strict construction will be applied against any party.

 

2.12         Remedies.
The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Buyer by vitiating
the intent and purpose of the transaction contemplated hereby. Accordingly, the Company acknowledges that the remedy at law for
a breach of its obligations under this Agreement will be inadequate and agrees, in the event of a breach or threatened breach by
the Company of the provisions of this Agreement, that the Buyer shall be entitled, in addition to all other available remedies
at law or in equity, and in addition to the penalties assessable herein, to an injunction or injunctions restraining, preventing
or curing any breach of this Agreement and to enforce specifically the terms and provisions hereof, without the necessity of showing
economic loss and without any bond or other security being required.

 

    	 	4	 

     

    

 

2.13         Buyer’s
Rights and Remedies Cumulative. All rights, remedies, and powers conferred in this Agreement and the Transaction Documents
on the Buyer are cumulative and not exclusive of any other rights or remedies, and shall be in addition to every other right, power,
and remedy that the Buyer may have, whether specifically granted in this Agreement or any other Transaction Document, or existing
at law, in equity, or by statute; and any and all such rights and remedies may be exercised from time to time and as often and
in such order as the Buyer may deem expedient.

 

2.14         Ownership
Limitation. If at any time after the Closing, the Buyer shall or would receive shares of Common Stock in payment of interest
or principal under Note, upon exercise of the Warrant, so that the Buyer would, together with other shares of Common Stock held
by it or its Affiliates, own or beneficially own by virtue of such action or receipt of additional shares of Common Stock a number
of shares exceeding 9.99% of the number of shares of Common Stock outstanding on such date (the “Maximum Percentage”),
the Company shall not be obligated and shall not issue to the Buyer shares of Common Stock which would exceed the Maximum Percentage,
but only until such time as the Maximum Percentage would no longer be exceeded by any such receipt of shares of Common Stock by
the Buyer. The foregoing limitations are enforceable, unconditional and non-waivable and shall apply to all Affiliates and assigns
of the Buyer.

 

Attorneys’
Fees and Cost of Collection. In the event of any action at law or in equity to enforce or interpret the terms of this Agreement
or any of the other Transaction Documents, the parties agree that the party who is awarded the most money shall be deemed the prevailing
party for all purposes and shall therefore be entitled to an additional award of the full amount of the attorneys’ fees and
expenses paid by such prevailing party in connection with the litigation and/or dispute without reduction or apportionment based
upon the individual claims or defenses giving rise to the fees and expenses. Nothing herein shall restrict or impair a court’s
power to award fees and expenses for frivolous or bad faith pleading.

 

[Remainder of page intentionally
left blank; signature page to follow]

 

    	 	5	 

     

    

 

	SUBSCRIPTION AMOUNT:	 	 	 
	 	 	 	 
	Original Principal Amount of Note:	 	$	38,500.00	 
	Purchase Price:	 	$	35,000.00	 

 

IN WITNESS WHEREOF, the
undersigned Buyer and the Company have caused this Agreement to be duly executed as of the date first above written.

 

	THE COMPANY:	 
	 	 
	Arkados Group, Inc.	 
	 	 	 
	By:	/s/ Terrence DeFranco	 
	 	Mr. Terrence DeFranco	 
	 	Chief Executive Officer	 
	 	 	 
	THE BUYER:	 
	 	 
	Lucas Hoppel	 
	 	 
	By:	/s/ Lucas Hoppel	 

 

     

     

    

 

EXHIBIT A

 

NOTEExhibit 10.3

 

SECURITIES PURCHASE AGREEMENT

 

This SECURITIES
PURCHASE AGREEMENT (the “Agreement”), dated as of the 6th day of April, 2017, by and between ARKADOS
GROUP, INC., a Delaware corporation, with headquarters located at 211 Warren Street, Suite 320, Newark, NJ 07103 (the
“Company”), and the
undersigned with principal address set forth on the Purchaser Signature and Subscription Page hereto (the
“Purchaser”).

 

WHEREAS:

 

A.           The
Company and the Purchaser are executing and delivering this Agreement in reliance upon the Regulation S or Regulation D exemption
from securities registration afforded by the rules and regulations as promulgated by the United States Securities and Exchange
Commission (the “SEC”) under the Securities Act of 1933, as amended (the “1933 Act”), or under Section
4(a)(2) of the 1933 Act;

 

B.           Purchaser
desires to purchase, and the Company desires to issue and sell, upon the terms and conditions set forth in this Agreement, such
number of shares of common stock, par value $0.0001 of the Company (the “Common Stock”) set forth on the Purchaser
Signature and Subscription Page for the aggregate purchase price stated on the Purchaser Signature and Subscription Page (the “Purchase
Price), as well as a warrant to acquire such equal number of shares of common stock at an exercise price of $1.00 per share (the
“Warrant” and the shares of the shares of Common Stock issuable upon exercise of or otherwise pursuant to the Warrants,
collectively, the “Warrant Shares”). The Common Stock together with the Warrant shall be referred to hereinafter as
the “Offered Units”).

 

NOW THEREFORE,
in consideration of the premises and the mutual covenants contained herein and other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the parties agree as follows:

 

1.          Closing.

 

a.           On
or before the Closing Date (as defined below), (i) the Purchaser shall pay to the Company by wire transfer of immediately available
funds in accordance with the Company’s written wiring instructions, the Purchase Price. The Company, upon confirmation of
the receipt of funds, but in no event later than the Closing Date, shall deliver instructions to its transfer agent to issue the
Common Stock to Purchaser and shall likewise promptly issue the Warrants accompanying such purchased Common Stock to Purchaser.

 

b.           Subject
to the satisfaction (or written waiver) of the conditions thereto set forth in Section 5 and Section 6 below, the date and time
of the issuance and sale of the Offered Units pursuant to this Agreement (the “Closing Date”) shall be 5:00 p.m., Eastern
Daylight Time on or about April __, 2017, or such other mutually agreed upon time. The closing of the transactions contemplated
by this Agreement (the “Closing”) shall occur on the Closing Date at such location as may be agreed to by the parties.

 

     

     

    

  

2.          Purchaser’s
Representations and Warranties. The Purchaser represents and warrants to the Company that:

 

a.           Investment
Purpose. The Purchaser is purchasing the Offered Units for its own account and not with a present view towards the public sale
or distribution thereof, except pursuant to sales registered or exempted from registration under the 1933 Act.

 

b.           Accredited
Investor Status. The Purchaser (i) an “accredited investor” as that term is defined in Rule 501 of the General
Rules and Regulations under the 1933 Act by reason of Rule 501(a)(3) (an “Accredited Investor”), (ii) experienced in
making investments of the kind described in this Agreement and the related documents, (iii) able, by reason of the business and
financial experience of its officers (if an entity) and professional advisors (who are not affiliated with or compensated in any
way by the Company or any of its affiliates or selling agents), to protect its own interests in connection with the transactions
described in this Agreement, and the related documents, and (iv) able to afford the entire loss of its investment in the Offered
Units.

 

c.           Reliance
on Exemptions. The Purchaser understands that the Offered Units are being offered and sold to it in reliance upon specific
exemptions from the registration requirements of United States federal and state securities laws and that the Company is relying
upon the truth and accuracy of, and the Purchaser’s compliance with, the representations, warranties, agreements, acknowledgments
and understandings of the Purchaser set forth herein in order to determine the availability of such exemptions and the eligibility
of the Purchaser to acquire the Offered Units.

 

d.           Information.
The Purchaser and its advisors, if any, have been furnished with all materials relating to the business, finances and operations
of the Company and materials relating to the offer and sale of the Offered Units which have been requested by the Purchaser. Without
limiting the generality of the foregoing, Buyer has also had the opportunity to obtain and to review the Company’s most recent
Annual Report on Form 10-K for the fiscal year ended May 31, 2016, and Quarterly Report on Form 10-Q for the fiscal quarter ended
November 30, 2016 (collectively, the “SEC Documents”). The Purchaser and its advisors, if any, have been afforded the
opportunity to ask questions of the Company and to promptly receive answers to those questions. Notwithstanding the foregoing,
the Company has not disclosed to the Purchaser any material nonpublic information and will not disclose such information unless
such information is disclosed to the public prior to or promptly following such disclosure to the Purchaser, or unless Purchaser
enters into a non-disclosure agreement with the Company agreeing to maintain the confidentiality of the such information. Neither
such inquiries nor any other due diligence investigation conducted by Purchaser or any of its advisors or representatives shall
modify, amend or affect Purchaser’s right to rely on the Company’s representations and warranties contained in Section
3 below. The Purchaser understands that its investment in the Offered Units iinvolves a significant degree of risk.

 

    	2

     

    

 

e.           Governmental
Review. The Purchaser understands that no United States federal or state agency or any other government or governmental agency
has passed upon or made any recommendation or endorsement of the purchase or sale of the Offered Units.

 

f.            Transfer
or Re-sale. The Purchaser understands that (i) the sale or re-sale of the Common Stock and the Warrants has not been and is
not being registered under the 1933 Act or any applicable state securities laws, and the Offered Units may not be transferred unless
(a) the Common Stock or the Warrants are sold pursuant to an effective registration statement under the 1933 Act, (b) the
Purchaser shall have delivered to the Company, at the cost of the Purchaser, an opinion of counsel that shall be in form, substance
and scope customary for opinions of counsel in comparable transactions to the effect that the Offered Units to be sold or transferred
may be sold or transferred pursuant to an exemption from such registration, which opinion shall be reasonably acceptable to the
Company, (c) the Offered Units are sold or transferred to an “affiliate” (as defined in Rule 144 promulgated under
the 1933 Act (or a successor rule) (“Rule 144”)) of the Purchaser who agrees to sell or otherwise transfer the Offered
Units only in accordance with this Section 2(f) and who is an Accredited Investor, (d) the Offered Units are sold pursuant
to Rule 144, or (e) the Offered Units are sold pursuant to Regulation S under the 1933 Act (or a successor rule) (“Regulation
S”), and the Purchaser shall have delivered to the Company, at the cost of the Purchaser, an opinion of counsel that shall
be in form, substance and scope customary for opinions of counsel in corporate transactions, which opinion shall be reasonably
acceptable to the Company; (ii) any sale of such Offered Units made in reliance on Rule 144 may be made only in accordance with
the terms of said Rule and further, if said Rule is not applicable, any re-sale of such Offered Units under circumstances in which
the seller (or the person through whom the sale is made) may be deemed to be an underwriter (as that term is defined in the 1933
Act) may require compliance with some other exemption under the 1933 Act or the rules and regulations of the SEC thereunder; and
(iii) neither the Company nor any other person is under any obligation to register such Offered Units under the 1933 Act or any
state securities laws or to comply with the terms and conditions of any exemption thereunder (in each case).

 

g.           Legends.
The Purchaser understands that the Offered Units may only be sold pursuant to Rule 144, or Regulation S without any restriction
as to the number of securities as of a particular date that can then be immediately sold and the shares of Common Stock and the
Warrant may bear a restrictive legend in substantially the following form (and a stop-transfer order may be placed against transfer
of the certificates for such ssecurities):

 

    	3

     

    

 

“THE SHARES REPRESENTED
BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THE SHARES HAVE BEEN ACQUIRED FOR INVESTMENT
AND MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AND WITH RESPECT TO
THE SHARES OR AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF SAID ACT THAT IS THEN APPLICABLE TO THE SHARES, AS TO WHICH A
PRIOR OPINION OF COUNSEL ACCEPTABLE TO THE ISSUER OR TRANSFER AGENT MAY BE REQUIRED.”

 

The legend
set forth above shall be removed, and the Company shall issue a certificate without such legend to the holder of any Security upon
which it is stamped, if, unless otherwise required by applicable state securities laws, (a) such Security is registered for sale
under an effective registration statement filed under the 1933 Act or otherwise may be sold pursuant to Rule 144 or Regulation
S without any restriction as to the number of securities as of a particular date that can then be immediately sold, or (b) such
holder provides the Company with an opinion of counsel, in form, substance and scope customary for opinions of counsel in comparable
transactions, to the effect that a public sale or transfer of such Security may be made without registration under the 1933 Act,
which opinion shall be reasonably acceptable to the Company so that the sale or transfer is effected.

 

h.           Organization;
Authorization; Enforcement. Purchaser is duly organized, validly existing and in good standing under the laws of the jurisdiction
of its organization. This Agreement and any additional transaction agreements relating to the Offered Units, have been duly and
validly authorized, executed and delivered on behalf of the Purchaser and create a valid and binding agreement of the Purchaser
enforceable in accordance with its terms, subject as to enforceability to general principles of equity and to bankruptcy, insolvency,
moratorium and other similar laws affecting the enforcement of creditors’ rights generally.

 

i.            Investment
Risk. Purchaser understands that its investment in the Offered Units constitutes high risk investment, its investment in the Offered
Units involves a high degree of risk, including the risk of loss of the Purchaser’s entire investment

 

j.            Residency.
The state in which any offer to sell Securities hereunder was made to or accepted by the Purchaser is the state shown as the Buyer’s
address contained herein, and Purchaser is a resident of such state only.

 

    	4

     

    

 

3.           Representations
and Warranties of the Company. The Company represents and warrants to the Purchaser that:

 

a.           Organization
and Qualification. The Company is a corporation duly organized, validly existing and in good standing under the laws of Delaware,
with full power and authority (corporate and other) to own, lease, use and operate its properties and to carry on its business
as and where now owned, leased, used, operated and conducted. Each of the Subsidiaries (as defined below), if any, of the Company
is a corporation or other form of business entity duly organized, validly existing and in good standing under the laws of its jurisdiction
or organization, with full power and authority (corporate and other) to own, lease, use and operate its properties and to carry
on its business as and where now owned, leased, used, operated and conducted. The Company and each of its Subsidiaries is duly
qualified as a foreign corporation to do business and is in good standing in every jurisdiction in which its ownership or use of
property or the nature of the business conducted by it makes such qualification necessary except where the failure to be so qualified
or in good standing would not have a Material Adverse Effect. “Material Adverse Effect” means any material adverse
effect on the business, operations, assets, financial condition or prospects of the Company or its Subsidiaries, if any, taken
as a whole, or on the transactions contemplated hereby or by the agreements or instruments to be entered into in connection herewith.
“Subsidiaries” means any corporation or other organization, whether incorporated or unincorporated, in which the Company
owns, directly or indirectly, any equity or other ownership interest.

 

b.           Authorization;
Enforcement. (i) The Company has all requisite corporate power and authority to enter into and perform this Agreement, and
to consummate the transactions contemplated hereby and thereby and to issue the Offered Units, in accordance with the terms hereof,
(ii) the execution and delivery of this Agreement, the Offered Units by the Company and the consummation by it of the transactions
contemplated hereby and thereby (including without limitation, the issuance of the Offered Units) have been duly authorized by
the Company’s Board of Directors, (iii) this Agreement has been duly executed and delivered by the Company by its authorized
representative, and such authorized representative is the true and official representative with authority to sign this Agreement
and the other documents executed in connection herewith and bind the Company accordingly, and (iv) this Agreement constitutes,
and upon execution and delivery by the Company of the Offered Units, each of such instruments will constitute, a legal, valid and
binding obligation of the Company enforceable against the Company in accordance with its terms subject as to enforceability to
general principles of equity and to bankruptcy, insolvency, moratorium, and other similar laws affecting the enforcement of creditors’
rights generally.

 

    	5

     

    

 

c.           Capitalization.
As of the date hereof, the authorized capital stock of the Company consists of: (i) 600,000,000 shares of Common Stock, $0.0001
par value per share, of which 14,163,763 shares are issued and outstanding, and for which 10,456,054 shares are issuable for derivative
securities outstanding and approximately 146,000 shares are intended to settle outstanding pre-2010 unsecured debt obligations;
and (ii) 5,000,000 shares of Preferred Stock, $0.0001 par value per share, of which no shares are issued and outstanding; All of
such outstanding shares of capital stock are, or upon issuance will be, duly authorized, validly issued, fully paid and non-assessable.
No shares of capital stock of the Company are subject to preemptive rights or any other similar rights of the shareholders of the
Company or any liens or encumbrances imposed through the actions or failure to act of the Company. As of the effective date of
this Agreement, except for those disclosed in the Company’s filed reports with the SEC and options that may be issued to
executives of the Company (i) there are no other outstanding options, warrants, scrip, rights to subscribe for, puts, calls, rights
of first refusal, agreements, understandings, claims or other commitments or rights of any character whatsoever relating to, or
securities or rights convertible into or exchangeable for any shares of capital stock of the Company or any of its Subsidiaries,
or, with the exception of pending obligations to issue incentive options to executive officers of the Company pursuant to employment
contracts, no arrangements by which the Company or any of its Subsidiaries is or may become bound to issue additional shares of
capital stock of the Company or any of its Subsidiaries that are not mentioned here, (ii) there are no agreements or arrangements
under which the Company or any of its Subsidiaries is obligated to register the sale of any of its or their securities under the
1933 Act and (iii) there are no anti-dilution or price adjustment provisions contained in any security issued by the Company (or
in any agreement providing rights to security holders) that will be triggered by the issuance of the Offered Units that are not
contained here. The Company has made available to the Purchaser true and correct copies of the Company’s Certificate of Incorporation
as in effect on the date hereof (“Certificate of Incorporation”), and the Company’s By-laws, as in effect on
the date hereof (the “By-laws”).

 

d.           Issuance
of Shares. The Common Stock is duly authorized and will be validly issued, fully paid and non-assessable, and free from all
taxes, liens, claims and encumbrances with respect to the issue thereof and shall not be subject to preemptive rights or other
similar rights of shareholders of the Company and will not impose personal liability upon the holder thereof.

 

e.           No
Conflicts; Approvals. The execution, delivery and performance of this Agreement, the Offered Units by the Company and the consummation
by the Company of the transactions contemplated hereby and thereby will not (i) conflict with or result in a violation of any provision
of the Certificate of Incorporation or By-laws, or (ii) violate or conflict with, or result in a breach of any provision of, or
constitute a default (or an event which with notice or lapse of time or both could become a default) under, or give to others any
rights of termination, amendment, acceleration or cancellation of, any agreement, indenture, patent, patent license or instrument
to which the Company or any of its Subsidiaries is a party, or (iii) result in a violation of any law, rule, regulation, order,
judgment or decree (including federal and state securities laws and regulations and regulations of any self-regulatory organizations
to which the Company or its securities are subject) applicable to the Company or any of its Subsidiaries or by which any property
or asset of the Company or any of its Subsidiaries is bound or affected (except for such conflicts, defaults, terminations, amendments,
accelerations, cancellations and violations as would not, individually or in the aggregate, have a Material Adverse Effect). There
are no required consents, authorizations or orders of, or filings or registrations with, any court, governmental agency, regulatory
agency, self-regulatory organization or stock market or any third party in order for it to execute, deliver or perform any of its
obligations under this Agreement, to issue the Common Stock. All consents, authorizations, orders, filings and registrations which
the Company is required to obtain pursuant to the preceding sentence have been obtained or effected on or prior to the date hereof.

 

    	6

     

    

 

f.            SEC
Documents; Financial Statements. The Company is subject to the reporting requirements of the 1934 Act. The Company is current
on its reporting obligations with the SEC pursuant to the Securities Exchange Act of 1934, as amended (the “1934 Act”).
As of their respective dates, any reports filed within the last fiscal year, as amended, complied in all material respects with
the requirements of the 1934 Act and the rules and regulations of the SEC promulgated thereunder applicable to the SEC Documents,
and none of such reports, as amended, contained any untrue statement of a material fact or omitted to state a material fact required
to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were
made, not misleading. As of their respective dates, the financial statements of the Company included in the SEC Documents complied
as to form in all material respects with applicable accounting requirements and the published rules and regulations of the SEC
with respect thereto. Such financial statements have been prepared in accordance with United States generally accepted accounting
principles, consistently applied, during the periods involved and fairly present in all material respects the consolidated financial
position of the Company and its consolidated Subsidiaries as of the dates thereof and the consolidated results of their operations
and cash flows for the periods then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments).

 

g.           Absence
of Certain Changes. Since November 30, 2016, when viewed from the perspective of the Company and its Subsidiaries taken as
a whole, there has been no material adverse change and no material adverse development in the assets, liabilities, business, properties,
operations, financial condition, results of operations, of the Company or any of its Subsidiaries.

 

h.           Absence
of Litigation. There is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board,
government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its Subsidiaries,
threatened against or affecting the Company or any of its Subsidiaries, or their officers or directors in their capacity as such,
that could have a Material Adverse Effect.

 

    	7

     

    

 

i.            Patents,
Copyrights, etc. The Company and each of its Subsidiaries owns or possesses the requisite licenses or rights to use all patents,
patent applications, patent rights, inventions, know-how, trade secrets, trademarks, trademark applications, service marks, service
names, trade names and copyrights (“Intellectual Property”) necessary to enable it to conduct its business as now operated
(and, as presently contemplated to be operated in the future); there is no claim or action by any person pertaining to, or proceeding
pending, or to the Company’s knowledge threatened, which challenges the right of the Company or of a Subsidiary with respect
to any Intellectual Property necessary to enable it to conduct its business as now operated (and, as presently contemplated to
be operated in the future).

 

j.            Tax
Status. The Company and each of its Subsidiaries has made or filed all federal, state and foreign income and all other tax
returns, reports and declarations required by any jurisdiction to which it is subject (unless and only to the extent that the Company
and each of its Subsidiaries has set aside on its books provisions reasonably adequate for the payment of all unpaid and unreported
taxes) and has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to
be due on such returns, reports and declarations, except those being contested in good faith and has set aside on its books provisions
reasonably adequate for the payment of all taxes for periods subsequent to the periods to which such returns, reports or declarations
apply. There are no unpaid taxes claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company
know of no basis for any such claim. The Company has not executed a waiver with respect to the statute of limitations relating
to the assessment or collection of any foreign, federal, state or local tax. None of the Company’s tax returns is presently
being audited by any taxing authority, nor is the Company subject to any tax investigation by any governmental agency.

 

k.          Certain
Transactions. Except for arm’s length transactions pursuant to which the Company or any of its Subsidiaries makes payments
in the ordinary course of business upon terms no less favorable than the Company or any of its Subsidiaries could obtain from third
parties and other than the grant of stock options to officers of the Company, none of the officers, directors, or employees of
the Company is presently a party to any transaction with the Company or any of its Subsidiaries (other than for services as employees,
officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or
by, providing for rental of real or personal property to or from, or otherwise requiring payments to or from any officer, director
or such employee or, to the knowledge of the Company, any corporation, partnership, trust or other entity in which any officer,
director, or any such employee has a substantial interest or is an officer, director, trustee or partner.

 

l.            Disclosure.
There is no fact known to the Company (other than general economic conditions known to the public generally or as disclosed in
the SEC Documents) that has not been disclosed in writing to the Purchaser that (i) would reasonably be expected to have a Material
Adverse Effect, (ii) would reasonably be expected to materially and adversely affect the ability of the Company to perform its
obligations pursuant to this Agreement.

 

    	8

     

    

 

m.          Acknowledgment
Regarding Purchase of Securities. The Company acknowledges and agrees that the Purchaser is acting solely in the capacity of
arm’s length purchaser with respect to this Agreement and the transactions contemplated hereby. The Company further acknowledges
that the Purchaser is not acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to
this Agreement and the transactions contemplated hereby and any statement made by the Purchaser or any of its respective representatives
or agents in connection with this Agreement and the transactions contemplated hereby is not advice or a recommendation and is merely
incidental to the Purchaser’s purchase of the Offered Units. The Company further represents to the Purchaser that the Company’s
decision to enter into this Agreement has been based solely on the independent evaluation of the Company and its representatives.

 

n.           No
Integrated Offering. Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf, has directly
or indirectly made any offers or sales in any security or solicited any offers to buy any security under circumstances that would
require registration under the 1933 Act of the issuance of the Offered Units to the Purchaser. The issuance of the Offered Units
to the Purchaser will not be integrated with any other issuance of the Company’s securities (past, current or future) for
purposes of any shareholder approval provisions applicable to the Company or its securities.

 

o.           No
Brokers. The Company has taken no action which would give rise to any claim by any person for brokerage commissions, transaction
fees or similar payments relating to this Agreement or the transactions contemplated hereby.

 

p.           Permits;
Compliance. The Company and each of its Subsidiaries is in possession of all franchises, grants, authorizations, licenses,
permits, easements, variances, exemptions, consents, certificates, approvals and orders necessary to own, lease and operate its
properties and to carry on its business as it is now being conducted (collectively, the “Company Permits”), and there
is no action pending or, to the knowledge of the Company, threatened regarding suspension or cancellation of any of the Company
Permits. Neither the Company nor any of its Subsidiaries is in conflict with, or in default or violation of, any of the Company
Permits, except for any such conflicts, defaults or violations which, individually or in the aggregate, would not reasonably be
expected to have a Material Adverse Effect. Since November 30, 2013, neither the Company nor any of its Subsidiaries has received
any notification with respect to possible conflicts, defaults or violations of applicable laws, except for notices relating to
possible conflicts, defaults or violations, which conflicts, defaults or violations would not have a Material Adverse Effect.

 

    	9

     

    

 

q.           Environmental
Matters. The Company is in compliance with all applicable Environmental Laws in all respects except where the failure to comply
does not have and could not reasonably be expected to have a Material Adverse Effect. For purposes of the foregoing:

 

“Environmental
Laws” means, collectively, the Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended,
the Superfund Amendments and Reauthorization Act of 1986, the Resource Conservation and Recovery Act, the Toxic Substances Control
Act, as amended, the Clean Air Act, as amended, the Clean Water Act, as amended, any other “Superfund” or “Superlien”
law or any other applicable federal, state or local statute, law, ordinance, code, rule, regulation, order or decree regulating,
relating to, or imposing liability or standards of conduct concerning, the environment or any Hazardous Material.

 

“Hazardous
Material” means and includes any hazardous, toxic or dangerous waste, substance or material, the generation, handling, storage,
disposal, treatment or emission of which is subject to any Environmental Law.

 

r.            Title
to Property. The Company and its Subsidiaries have good and marketable title in fee simple to all real property and good and
marketable title to all personal property owned by them which is material to the business of the Company and its Subsidiaries,
in each case free and clear of all liens, encumbrances and defects or such as would not have a Material Adverse Effect. Any real
property and facilities held under lease by the Company and its Subsidiaries are held by them under valid, subsisting and enforceable
leases with such exceptions as would not have a Material Adverse Effect.

 

s.          Insurance.
The Company and each of its Subsidiaries are insured by insurers of recognized financial responsibility against such losses and
risks and in such amounts as management of the Company believes to be prudent and customary in the businesses in which the Company
and its Subsidiaries are engaged. Neither the Company nor any such Subsidiary has any reason to believe that it will not be able
to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers
as may be necessary to continue its business at a cost that would not have a Material Adverse Effect.

 

t.            Internal
Accounting Controls. The Company maintains a system of internal accounting controls sufficient, in the judgment of the Company’s
Board of Directors, to provide reasonable assurance that (i) transactions are executed in accordance with management’s general
or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity
with generally accepted accounting principles and to maintain asset accountability, (iii) access to assets is permitted only in
accordance with management’s general or specific authorization and (iv) the recorded accountability for assets is compared
with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences.

 

    	10

     

    

 

u.           Foreign
Corrupt Practices. Neither the Company, nor any of its Subsidiaries, nor any director, officer, agent, employee or other person
acting on behalf of the Company or any Subsidiary has, in the course of his actions for, or on behalf of, the Company, used any
corporate funds for any unlawful contribution, gift, entertainment or other unlawful expenses relating to political activity; made
any direct or indirect unlawful payment to any foreign or domestic government official or employee from corporate funds; violated
or is in violation of any provision of the U.S. Foreign Corrupt Practices Act of 1977, as amended, or made any bribe, rebate, payoff,
influence payment, kickback or other unlawful payment to any foreign or domestic government official or employee.

 

v.           No
Investment Company. The Company is not, and upon the issuance and sale of the Offered Units as contemplated by this Agreement
will not be an “investment company” required to be registered under the Investment Company Act of 1940 (an “Investment
Company”). The Company is not controlled by an Investment Company.

 

4.          COVENANTS.

 

a.           Best
Efforts. The parties shall use their reasonable best efforts to satisfy timely each of the conditions described in Section
5 and 6 of this Agreement.

 

b.           Form
D; Blue Sky Laws. Unless it believes it is exempt from any such filings, the Company agrees to file a Form D with respect to
the Offered Units as required under Regulation D and to provide a copy thereof to the Purchaser promptly after such filing. The
Company shall, on or before the Closing Date, take such action as the Company shall reasonably determine is necessary to qualify
the Offered Units for sale to the Purchaser at the applicable closing pursuant to this Agreement under applicable securities or
“blue sky” laws of the states of the United States (or to obtain an exemption from such qualification), and shall provide
evidence of any such action so taken to the Purchaser on or prior to the Closing Date.

 

c.           Use
of Proceeds. The Company shall use the proceeds for general working capital purposes, including legal and accounting expenses
related to SEC filings.

 

d.           Listing.
The Company will comply in all respects with the Company’s reporting, filing and other obligations under the bylaws or rules
to maintain listing on the pink sheets or any equivalent replacement exchange, as applicable. .

 

e.           No
Integration. The Company shall not knowingly make any offers or sales of any security (other than the Offered Units) under
circumstances that would require registration of the ssecurities being offered or sold hereunder under the 1933 Act or cause the
offering of the ssecurities to be integrated with any other offering of securities by the Company for the purpose of any stockholder
approval provision applicable to the Company or its securities.

 

    	11

     

    

 

5.          REGISTRATION
RIGHTS.

 

a.           As
promptly as possible, and in any event on or prior to the date that is seventy four (74) days after the Closing Date (the “Initial
Filing Date”), the Company shall prepare and file with the SEC a Registration Statement covering the resale of all of
the Common Stock and the Warrant Shares issued or issuable pursuant to the Transaction Documents (collectively, the “Registrable
Securities”), without taking into account any securities issued or issuable upon any stock split, dividend or other distribution,
recapitalization or similar event with respect to the foregoing Registrable Securities for an offering to be made on a continuous
basis pursuant to Rule 415. The Registration Statement shall be on Form S-3 (except if the Company is not then eligible to register
for resale the Registrable Securities on Form S-3, in which case such registration shall be on another appropriate form in accordance
with the 1933 Act and the 1934 Act) and shall contain (except if otherwise requested by the SEC) the “Plan of Distribution”
in substantially the form attached hereto as Annex B. To the extent the staff of the SEC does not permit all of the Registrable
Securities to be registered on the initial Registration Statement filed pursuant to this Section 5(a) (the “Initial Registration
Statement”), the Company shall file additional Registration Statements (each an “Additional Registration Statement”),
as promptly as possible, and in any event on or prior to the Additional Filing Date, successively trying to register on each such
Additional Registration Statement the maximum number of remaining Registrable Securities until all of the Registrable Securities
have been registered with the SEC.

 

b.           The
Company shall use its commercially reasonable efforts to cause each Registration Statement to be declared effective by the SEC
as promptly as possible after the filing thereof, but in any event prior to the applicable Required Effectiveness Date, and shall
use its commercially reasonable efforts to keep the Registration Statement continuously effective under the 1933 Act until the
earlier of the date that all Registrable Securities covered by such Registration Statement have been sold or can be sold publicly
without restriction or limitation under Rule 144 (including, without limitation, the requirement to be in compliance with Rule
144(c)(1)) (the “Effectiveness Period”); provided that, upon notification by the SEC that a Registration Statement
will not be reviewed or is no longer subject to further review and comments, the Company shall request acceleration of such Registration
Statement within three (3) Trading Days after receipt of such notice and request that it becomes effective on 4:00 p.m. New York
City time on the Effective Dave and file a prospectus supplement for any Registration Statement, whether or not required under
Rule 424 (or otherwise), by 9:00 a.m. New York City time the day after the Effective Date.

 

c.           The
Company shall notify the Purchasers in writing promptly (and in any event within two Trading Days) after receiving notification
from the SEC that a Registration Statement has been declared effective.

 

    	12

     

    

 

d.           Should
an Event (as defined below) occur, then upon the occurrence of such Event, and on every monthly anniversary thereof until the applicable
Event is cured, the Company shall pay to each Purchaser an amount in cash, as liquidated damages and not as a penalty, equal to
one percent (1.0%) of the aggregate Purchase Price of the Registrable Securities then held by the Purchaser; provided, however,
that the total amount of payments pursuant to this Section 5(d) shall not exceed, when aggregated with all such payments paid to
all Purchasers, ten percent (10%) of the aggregate Purchase Price hereunder. The payments to which a Purchaser shall be entitled
pursuant to this Section 5(d) are referred to herein as “Event Payments.” Any Event Payments payable pursuant
to the terms hereof shall apply on a pro-rated basis for any portion of a month prior to the cure of an Event. All pro-rated calculations
made pursuant to this paragraph shall be based upon the actual number of days in such pro-rated month. Each of the following shall
constitute an “Event”:

 

(i)          a
Registration Statement is not filed on or prior to its Filing Date or is not declared effective on or prior to its Required Effectiveness
Date or does not register all Registrable Securities; provided that if the SEC, by written or oral comment or otherwise, limits
the Company’s ability to request effectiveness, or prohibits the effectiveness of, a Registration Statement with respect
to any or all the Registrable Securities pursuant to Rule 415, it shall not be a breach or default by the Company under this Agreement
and shall not be deemed a failure by the Company to use reasonable best efforts;

 

(ii)         except
as provided for in Section 5(e) (the “Excluded Events”), after the Effective Date of a Registration Statement, a Purchaser
is not permitted to sell Registrable Securities under the Registration Statement (or a subsequent Registration Statement filed
in replacement thereof) for any reason (other than the fault of such Purchaser) for five (5) or more Trading Days (whether or not
consecutive);

 

(iii)        except
as a result of the Excluded Events, the Common Stock is not listed or quoted, or is suspended from trading, on an Eligible Market
for a period of three Trading Days (which need not be consecutive Trading Days) during the Effectiveness Period; and

 

(iv)        at
any time during the period commencing from the six (6) month anniversary of the Closing Date and ending at the termination of the
Effectiveness Period, if a Registration Statement is not available for the resale of all of the Registrable Securities and the
Company shall fail for any reason to satisfy the current public information requirement under Rule 144(c); provided, that Event
Payments on the Registrable Securities may not accrue under more than one of the foregoing clauses (i), (ii), (iii) and (iv), at
any one time; and provided further, that (1) upon the filing of the Registration Statement as required hereunder (in the case of
Section 5(d)(i)), (2) upon the effectiveness of a Registration Statement as required hereunder (in the case of Section 5(d)(ii)),
(3) upon the resumed trading of the Common Stock (in the case of Section 5(d)(iii)), or (4) upon the resumption of a Purchasers
ability to resell the Registrable Securities under an effective Registration Statement or the Company’s satisfaction of the
current public information requirement under Rule 144(c) of the Securities Act (in the case of Section 5.1(d)(iv)), Event Payments
on the Registrable Securities as a result of such clause shall cease to accrue. It is understood and agreed that, notwithstanding
any provision to the contrary, no Event Payments shall accrue on any Registrable Securities that are then covered by, and may be
sold under, an effective Registration Statement.

 

    	13

     

    

 

e.           Notwithstanding
anything in this Agreement to the contrary:

 

(i)          notwithstanding
Section 5, the Company, upon written notice to the Purchasers, shall be permitted to suspend the availability of a Registration
Statement covering the Registrable Securities for any bona fide reason whatsoever for up to 15 consecutive days (the “Deferral
Period”) in any 90-day period without being obligated to pay liquidated damages; provided, that Deferral Periods may not
total more than 45 days in the aggregate in any twelve-month period. The Company shall not be required to specify in the written
notice to the Purchasers the nature of the event giving rise to the Deferral Period; and

 

(ii)         the
Company may, by written notice to the Purchasers, suspend sales under a Registration Statement after the Effective Date thereof
and/or require that the Purchasers immediately cease the sale of shares of Common Stock pursuant thereto and/or defer the filing
of any subsequent Registration Statement if the Company is engaged in a material merger, acquisition or sale and the Board of Directors
determines in good faith, by appropriate resolutions, that, as a result of such activity, (A) it would be materially detrimental
to the Company (other than as relating solely to the price of the Common Stock) to maintain a Registration Statement at such time
or (B) it is in the best interests of the Company to suspend sales under such registration at such time. Upon receipt of such notice,
each Purchaser shall immediately discontinue any sales of Registrable Securities pursuant to such registration until such Purchaser
is advised in writing by the Company that the current Prospectus or amended Prospectus, as applicable, may be used. In no event,
however, shall this right be exercised to suspend sales beyond the period during which (in the good faith determination of the
Company’s Board of Directors) the failure to require such suspension would be materially detrimental to the Company. The
Company’s rights under this Section 5(e) may be exercised for a period of no more than 20 calendar days at a time and not
more than three times in any twelve-month period, without such suspension being considered as part of an Event Payment determination.
Immediately after the end of any suspension period under this Section 5(e), the Company shall take all necessary actions (including
filing any required supplemental prospectus) to restore the effectiveness of the applicable Registration Statement and the ability
of the Purchasers to publicly resell their Registrable Securities pursuant to such effective Registration Statement.

 

f.            Registration
Procedures. In connection with the Company’s registration obligations hereunder, the Company shall:

 

    	14

     

    

 

(i)          Not
less than three Trading Days prior to the filing of a Registration Statement or any related Prospectus or any amendment or supplement
thereto, furnish via email to those Purchasers who have supplied the Company with email addresses copies of all such documents
proposed to be filed (or at the request of one or more Purchasers, only certain sections thereof), which documents (other than
any document that is incorporated or deemed to be incorporated by reference therein) will be subject to the review of such Purchasers.
The Company shall reflect in each such document when so filed with the SEC such comments regarding the Purchasers and the plan
of distribution as the Purchasers may reasonably and promptly propose no later than two Trading Days after the Purchasers have
been so furnished with copies of such documents as aforesaid.

 

(ii)         (A)
Subject to Section 5(e), prepare and file with the SEC such amendments, including post-effective amendments, to each Registration
Statement and the Prospectus used in connection therewith as may be necessary to keep the Registration Statement continuously effective,
as to the applicable Registrable Securities for the Effectiveness Period and prepare and file with the SEC such additional Registration
Statements in order to register for resale under the Securities Act all of the Registrable Securities; (B) cause the related Prospectus
to be amended or supplemented by any required Prospectus supplement, and as so supplemented or amended to be filed pursuant to
Rule 424; and (C) comply in all material respects with the provisions of the 1933 Act and the 1934 Act with respect to the disposition
of all Registrable Securities covered by the Registration Statement during the applicable period in accordance with the intended
methods of disposition by the Purchasers thereof set forth in the Registration Statement as so amended or in such Prospectus as
so supplemented.

 

(iii)        Notify
the Purchasers as promptly as reasonably possible, and if requested by the Purchasers, confirm such notice in writing no later
than two Trading Days thereafter, of any of the following events: (A) the SEC notifies the Company whether there will be a “review”
of any Registration Statement; (B) any Registration Statement or any post-effective amendment is declared effective; (C) the SEC
issues any stop order suspending the effectiveness of any Registration Statement or initiates any Proceedings for that purpose;
(D) the Company receives notice of any suspension of the qualification or exemption from qualification of any Registrable Securities
for sale in any jurisdiction, or the initiation or threat of any Proceeding for such purpose; or (E) the financial statements included
in any Registration Statement become ineligible for inclusion therein or any Registration Statement or Prospectus or other document
contains any untrue statement of a material fact or omits to state any material fact required to be stated therein or necessary
to make the statements therein, in the light of the circumstances under which they were made, not misleading.

 

(iv)        Use
its commercially reasonable efforts to avoid the issuance of or, if issued, obtain the withdrawal of (i) any order suspending the
effectiveness of any Registration Statement, or (ii) any suspension of the qualification (or exemption from qualification) of any
of the Registrable Securities for sale in any jurisdiction, as soon as possible.

 

    	15

     

    

 

(v)         If
requested by a Purchaser, provide such Purchaser, without charge, at least one conformed copy of each Registration Statement and
each amendment thereto, including financial statements and schedules, and all exhibits to the extent requested by such Purchaser
(including those previously furnished or incorporated by reference) promptly after the filing of such documents with the SEC.

 

(vi)        Promptly
deliver to each Purchaser, without charge, as many copies of the Prospectus or Prospectuses (including each form of prospectus)
and each amendment or supplement thereto as such Purchaser may reasonably request. The Company hereby consents to the use of such
Prospectus and each amendment or supplement thereto by each of the selling Purchasers in connection with the offering and sale
of the Registrable Securities covered by such Prospectus and any amendment or supplement thereto to the extent permitted by federal
and state securities laws and regulations.

 

(vii) (A)
In the time and manner required by each Trading Market on which the Common Stock is listed, prepare and file with such Trading
Market an additional shares listing application covering all of the Registrable Securities; (B) take all steps necessary to cause
such Registrable Securities to be approved for listing on each such Trading Market as soon as possible thereafter; (C) provide
to each Purchaser evidence of such approval; and (D) except as a result of the Excluded Events, during the Effectiveness Period,
maintain the listing of such Registrable Securities on each such Trading Market or another Eligible Market.

 

(viii)      Prior
to any public offering of Registrable Securities, use its commercially reasonable efforts to register or qualify or cooperate with
the selling Purchasers in connection with the registration or qualification (or exemption from such registration or qualification)
of such Registrable Securities for offer and sale under the securities or “blue sky” laws of such jurisdictions within
the United States as any Purchaser requests in writing, to keep each such registration or qualification (or exemption therefrom)
effective for so long as required, but not to exceed the duration of the Effectiveness Period, and to do any and all other acts
or things reasonably necessary or advisable to enable the disposition in such jurisdictions of the Registrable Securities covered
by a Registration Statement; provided , however , that the Company shall not be obligated to file any general consent to service
of process or to qualify as a foreign corporation or as a dealer in securities in any jurisdiction in which it is not so qualified
or to subject itself to taxation in respect of doing business in any jurisdiction in which it is not otherwise so subject.

 

(ix)         Cooperate
with the Purchasers to facilitate the timely preparation and delivery of certificates representing Registrable Securities to be
delivered to a transferee pursuant to a Registration Statement, which certificates shall be free, to the extent permitted by this
Agreement and under law, of all restrictive legends, and to enable such Registrable Securities to be in such denominations and
registered in such names as any such Purchasers may reasonably request.

 

    	16

     

    

 

(x)          Upon
the occurrence of any event described in Sections 5(f)(iii)(C), (D) or (E) , as promptly as reasonably possible, prepare a supplement
or amendment, including a post-effective amendment, to the Registration Statement or a supplement to the related Prospectus or
any document incorporated or deemed to be incorporated therein by reference, and file any other required document so that, as thereafter
delivered, neither the Registration Statement nor such Prospectus will contain an untrue statement of a material fact or omit to
state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading,

 

(xi)         Cooperate
with any reasonable due diligence investigation undertaken by the Purchasers in connection with the sale of Registrable Securities,
including, without limitation, by making available documents and information; provided that the Company will not deliver or make
available to any Purchaser material, nonpublic information.

 

(xii)        Comply
with all rules and regulations of the SEC applicable to the registration of the Registrable Securities.

 

(xiii)       It
shall be a condition precedent to the obligations of the Company to complete the registration pursuant to this Agreement with respect
to the Registrable Securities of any particular Purchaser or to make any Event Payments set forth in Section 5(c) to such Purchaser
that the intended method of disposition of the Registrable Securities held by it (if different from the Plan of Distribution set
forth on Exhibit B hereto) as shall be reasonably required to effect the registration of such Registrable Securities and shall
complete and execute such documents in connection with such registration as the Company may reasonably request.

 

(xiv)      The
Company shall comply with all applicable rules and regulations of the SEC under the Securities Act and the Exchange Act, including,
without limitation, Rule 172 under the Securities Act, file any final Prospectus, including any supplement or amendment thereof,
with the SEC pursuant to Rule 424 under the Securities Act, promptly inform the Purchasers in writing if, at any time during the
Effectiveness Period, the Company does not satisfy the conditions specified in Rule 172 and, as a result thereof, the Purchasers
are required to make available a Prospectus in connection with any disposition of Registrable Securities and take such other actions
as may be reasonably necessary to facilitate the registration of the Registrable Securities hereunder.

 

(xv)       Not
identify any Purchaser as an underwriter without its prior written consent in any public disclosure or filing with the SEC, the
Trading Market or any Eligible Market and any Purchaser being deemed an underwriter by the SEC shall not relieve the Company of
any obligations it has under this Agreement; provided , however , that the foregoing shall not prohibit the Company from including
the disclosure found in the “Plan of Distribution” section attached hereto as Annex B in the Registration Statement.
In addition, and notwithstanding anything to the contrary contained herein, if the Company has received a comment by the SEC requiring
an Purchaser to be named as an underwriter in the Registration Statement (which notwithstanding the reasonable best efforts of
the Company is not withdrawn by the SEC) and such Purchaser elects in writing not to be named as a selling stockholder in the Registration
Statement, the Purchaser shall not be entitled to any Event Payments with respect to such Registration Statement.

 

    	17

     

    

 

g.           Registration
Expenses. The Company shall pay all fees and expenses incident to the performance of or compliance with Section 5 of this Agreement
by the Company, including without limitation (i) all registration and filing fees and expenses, including without limitation those
related to filings with the SEC, any Trading Market, any required filing with the Financial Industry Regulatory Authority by the
Agents (but not any Purchaser), and in connection with applicable state securities or blue sky laws, (ii) printing expenses (including
without limitation expenses of printing certificates for Registrable Securities), (iii) messenger, telephone and delivery expenses,
(iv) fees and disbursements of counsel for the Company, (v) fees and expenses of all other Persons retained by the Company in connection
with the consummation of the transactions contemplated by this Agreement, and (vi) all listing fees to be paid by the Company to
the Trading Market.

 

h.           Indemnification.

 

(i)          Indemnification
by the Company. The Company shall, notwithstanding any termination of this Agreement, indemnify and hold harmless each Purchaser,
the officers, directors, partners, members, agents and employees of each of them, each Person who controls any such Purchaser (within
the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act) and the officers, directors, partners, members, agents
and employees of each such controlling Person, to the fullest extent permitted by applicable law, from and against any and all
Losses, as incurred, arising out of or relating to (A) any misrepresentation or breach of any representation or warranty made by
the Company in the Transaction Documents or any other certificate, instrument or document contemplated hereby or thereby, (B) any
breach of any covenant, agreement or obligation of the Company contained in the Transaction Documents or any other certificate,
instrument or document contemplated hereby or thereby, (C) any cause of action, suit or claim brought or made against such Indemnified
Party (as defined in Section 5(h)(iii) below) by a third party (including for these purposes a derivative action brought on behalf
of the Company), arising out of or resulting from (x) execution, delivery, performance or enforcement of the Transaction Documents
or any other certificate, instrument or document contemplated hereby or thereby, (y) any transaction financed or to be financed
in whole or in part, directly or indirectly, with the proceeds of the issuance of the Securities,
or (z) the status of Indemnified Party as holder of the Securities or (D) any untrue or alleged untrue statement of a material
fact contained in the Registration Statement, any Prospectus or any form of Company prospectus or in any amendment or supplement
thereto or in any Company preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material
fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus or form of prospectus
or supplement thereto, in the light of the circumstances under which they were made) not misleading, except to the extent, but
only to the extent, that (1) such untrue statements, alleged untrue statements, omissions or alleged omissions are based solely
upon information regarding such Purchaser furnished in writing to the Company by such Purchaser for use therein, or to the extent
that such information relates to such Purchaser or such Purchaser’s proposed method of distribution of Registrable Securities
and was reviewed and expressly approved by such Purchaser expressly for use in the Registration Statement, or (2) with respect
to any prospectus, if the untrue statement or omission of material fact contained in such prospectus was corrected on a timely
basis in the prospectus, as then amended or supplemented, if such corrected prospectus was timely made available by the Company
to the Purchaser, and the Purchaser seeking indemnity hereunder was advised in writing not to use the incorrect prospectus prior
to the use giving rise to Losses.

 

    	18

     

    

 

(ii)         Indemnification
by Purchasers. Each Purchaser shall, severally and not jointly, indemnify and hold harmless the Company, its directors, officers,
agents and employees, each Person who controls the Company (within the meaning of Section 15 of the 1933 Act and Section 20 of
the 1934 Act), and the directors, officers, agents or employees of such controlling Persons, to the fullest extent permitted by
applicable law, from and against all Losses (as determined by a court of competent jurisdiction in a final judgment not subject
to appeal or review) arising solely out of any untrue statement of a material fact contained in the Registration Statement, any
Prospectus, or any form of prospectus, or in any amendment or supplement thereto, or arising out of or relating to any omission
of a material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus or
form of prospectus or supplement thereto, in the light of the circumstances under which they were made) not misleading, but only
to the extent that such untrue statement or omission is contained in any information so furnished by such Purchaser in writing
to the Company specifically for inclusion in such Registration Statement or such Prospectus or to the extent that (i) such untrue
statements or omissions are based solely upon information regarding such Purchaser furnished to the Company by such Purchaser in
writing expressly for use therein, or to the extent that such information relates to such Purchaser or such Purchaser’s proposed
method of distribution of Registrable Securities and was reviewed and expressly approved by such Purchaser expressly for use in
the Registration Statement (it being understood that the Plan of Distribution set forth on Annex B constitutes information
reviewed and expressly approved by such Purchaser in writing expressly for use in the Registration Statement), such Prospectus
or such form of Prospectus or in any amendment or supplement thereto. In no event shall the liability of any selling Purchaser
hereunder be greater in amount than the dollar amount of the net proceeds received by such Purchaser upon the sale of the Registrable
Securities giving rise to such indemnification obligation.

 

(iii)       Conduct
of Indemnification Proceedings.

 

(A)         If
any Proceeding shall be brought or asserted against any Person entitled to indemnity hereunder (an “Indemnified Party”),
such Indemnified Party shall promptly notify the Person from whom indemnity is sought (the “Indemnifying Party”)
in writing, and the Indemnifying Party shall assume the defense thereof, including the employment of counsel reasonably satisfactory
to the Indemnified Party and the payment of all fees and expenses incurred in connection with defense thereof; provided, that the
failure of any Indemnified Party to give such notice shall not relieve the Indemnifying Party of its obligations or liabilities
pursuant to this Agreement, except (and only) to the extent that it shall be finally determined by a court of competent jurisdiction
(which determination is not subject to appeal or further review) that such failure shall have proximately and materially adversely
prejudiced the Indemnifying Party.

 

    	19

     

    

 

(B)         An
Indemnified Party shall have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof,
but the fees and expenses of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1) the Indemnifying
Party has agreed in writing to pay such fees and expenses; or (2) the Indemnifying Party shall have failed within 45 days of receiving
notification of a Proceeding from an Indemnified Party to assume the defense of such Proceeding and to employ counsel reasonably
satisfactory to such Indemnified Party in any such Proceeding; or (3) the named parties to any such Proceeding (including any impleaded
parties) include both such Indemnified Party and the Indemnifying Party, and such Indemnified Party shall have been advised by
counsel that a conflict of interest is likely to exist if the same counsel were to represent such Indemnified Party and the Indemnifying
Party (in which case, if such Indemnified Party notifies the Indemnifying Party in writing that it elects to employ separate counsel
at the expense of the Indemnifying Party, the Indemnifying Party shall not have the right to assume the defense thereof and the
reasonable fees and expenses of separate counsel shall be at the expense of the Indemnifying Party). It being understood, however,
that the Indemnifying Party shall not, in connection with any one such Proceeding (including separate Proceedings that have been
or will be consolidated before a single judge) be liable for the fees and expenses of more than one separate firm of attorneys
at any time for all Indemnified Parties, which firm shall be appointed by a majority of the Indemnified Parties. The Indemnifying
Party shall not be liable for any settlement of any such Proceeding effected without its written consent, which consent shall not
be unreasonably withheld. No Indemnifying Party shall, without the prior written consent of the Indemnified Party, effect any settlement
of any pending Proceeding in respect of which any Indemnified Party is a party, unless such settlement includes an unconditional
release of such Indemnified Party from all liability on claims that are the subject matter of such Proceeding.

 

(C)         All
reasonable fees and documented expenses of the Indemnified Party (including reasonable fees and expenses to the extent incurred
in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section) shall be
paid to the Indemnified Party, as incurred, within 20 Trading Days of written notice thereof to the Indemnifying Party (regardless
of whether it is ultimately determined that an Indemnified Party is not entitled to indemnification hereunder; provided, that the
Indemnifying Party may require such Indemnified Party to undertake to reimburse all such fees and expenses to the extent it is
finally judicially determined that such Indemnified Party is not entitled to indemnification hereunder.

 

    	20

     

    

 

(iv)        Contribution.
If a claim for indemnification under Section 5(h)(i) or (ii) is unavailable to an Indemnified Party (by reason of public policy
or otherwise), then each Indemnifying Party, in lieu of indemnifying such Indemnified Party, shall contribute to the amount paid
or payable by such Indemnified Party as a result of such Losses, in such proportion as is appropriate to reflect the relative fault
of the Indemnifying Party and Indemnified Party in connection with the actions, statements or omissions that resulted in such Losses
as well as any other relevant equitable considerations. The relative fault of such Indemnifying Party and Indemnified Party shall
be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement
of a material fact or omission or alleged omission of a material fact, has been taken or made by, or relates to information supplied
by, such Indemnifying Party or Indemnified Party, and the parties’ relative intent, knowledge, access to information and
opportunity to correct or prevent such action, statement or omission. The amount paid or payable by a party as a result of any
Losses shall be deemed to include, subject to the limitations set forth in Section 5(h)(iii), any reasonable attorneys’ or
other reasonable fees or expenses incurred by such party in connection with any Proceeding to the extent such party would have
been indemnified for such fees or expenses if the indemnification provided for in this Section 5 was available to such party in
accordance with its terms. The parties hereto agree that it would not be just and equitable if contribution pursuant to this Section
5(h)(iv) were determined by pro rata allocation or by any other method of allocation that does not take into account the equitable
considerations referred to in the immediately preceding paragraph. Notwithstanding the provisions of this Section 5(h)(iv), no
Purchaser shall be required to contribute, in the aggregate, any amount in excess of the amount by which the net proceeds actually
received by such Purchaser from the sale of the Registrable Securities subject to the Proceeding exceeds the amount of any damages
that such Purchaser has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged
omission. No Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the 1933 Act) shall be entitled
to contribution from any Person who was not guilty of such fraudulent misrepresentation.

 

(v)         Additional
Liability. The indemnity and contribution agreements contained in this Section 5 are in addition to any liability that the
Indemnifying Parties may have to the Indemnified Parties.

 

i.            Dispositions.
Each Purchaser agrees that it will comply with the prospectus delivery requirements of the Securities Act as applicable to it in
connection with sales of Registrable Securities pursuant to the Registration Statement and shall sell its Registrable Securities
in accordance with the Plan of Distribution set forth in the Prospectus. Each Purchaser further agrees that, upon receipt of a
notice from the Company of the occurrence of any event of the kind described in Sections 5(f)(iii)(C), (D) or (E), such Purchaser
will discontinue disposition of such Registrable Securities under the Registration Statement until such Purchaser is advised in
writing by the Company that the use of the Prospectus, or amended Prospectus, as applicable, may be used. The Company may provide
appropriate stop orders to enforce the provisions of this paragraph. Each Purchaser, severally and not jointly with the other Purchasers,
agrees that the removal of the restrictive legend from certificates representing Securities as set forth in Section 5 and elsewhere
in this Agreement is predicated upon the Company’s reliance that the Purchaser will comply with the provisions of this subsection.

 

    	21

     

    

 

j.         Definitions.
In addition to the terms defined elsewhere in this Agreement, the following terms have the meanings indicated:

 

“Additional
Filing Date” means the later of (i) the date sixty (60) days after the date substantially all of the Registrable
Securities registered under the immediately preceding Registration Statement are sold and (ii) the date six (6) months
from the Effective Date of the immediately preceding Registration Statement, or, if such date is not a Business Day, the next date
that is a Business Day.

 

“Additional Registration
Statement” has the meaning set forth in Section 5(a).

 

“Additional
Required Effectiveness Date ” means the date which is the earliest of (i) if the Registration Statement does not
become subject to review by the SEC, (a) sixty (60) days after the Additional Filing Date or (b) five (5) Trading
Days after the Company receives notification from the SEC that the Additional Registration Statement will not become subject to
review and the Company fails to request to accelerate the effectiveness of the Registration Statement, or (ii) if the Additional
Registration Statement becomes subject to review by the SEC, one hundred and twenty (120) days after the Additional Filing
Date, or, if such date is not a Business Day, the next date that is a Business Day.

 

“Business
Day” means any day other than Saturday, Sunday or other day on which commercial banks in the City of New York are authorized
or required by law to remain closed.

 

“Effective
Date” means the date that a Registration Statement is first declared effective by the SEC.

 

“Effectiveness Period”
has the meaning set forth in Section 5(b).

 

“Eligible
Market” means any of the following markets or exchanges on which the shares of Common Stock are listed or quoted for
trading on the date in question: the OTC Bulletin Board, The NASDAQ Global Market, The NASDAQ Global Select Market, The NASDAQ
Capital Market, the New York Stock Exchange, NYSE Arca, the NYSE MKT, or the OTCQX Marketplace or the OTCQB ad OTC Pink quotation
systems operated by OTC Markets Group Inc. (or any successor to any of the foregoing).

 

    	22

     

    

 

“Event”
has the meaning set forth in Section 5(d).

 

“Event
Payments” has the meaning set forth in Section 5(d).

 

“Excluded
Events” has the meaning set forth in Section 5(d)(ii).

 

“Filing
Date” means the Initial Filing Date and the Additional Filing Date, as applicable.

 

“Indemnified
Party” has the meaning set forth in Section 5(h)(iii)(A).

 

“Indemnifying
Party” has the meaning set forth in Section 5(h)(iii)(A).

 

“Initial Filing Date”
has the meaning set forth in Section 5(a).

 

“Initial
Registration Statement” has the meaning set forth in Section 5(a).

 

“Initial
Required Effectiveness Date” means the date which is the earliest of (i) if the Registration Statement does not
become subject to a full review by the SEC, (a) ninety (90) days after the Closing Date or (b) five (5) Trading
Days after the Company receives notification from the SEC that the Registration Statement will not become subject to review and
the Company fails to request to accelerate the effectiveness of the Registration Statement, or (ii) if the Registration Statement
becomes subject to a full review by the SEC, one hundred and twenty (120) days after the Closing Date, or, if such date is
not a Business Day, the next date that is a Business Day.

 

“Losses”
means any and all losses, claims, damages, liabilities, settlement costs and expenses, including, without limitation reasonable
attorneys’ fees.

 

“Person”
means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization
and a government or any department or agency thereof.

 

“Proceeding”
means an action, claim, suit, investigation or proceeding (including, without limitation, a partial proceeding, such as a deposition),
whether commenced or threatened in writing.

 

    	23

     

    

 

“Prospectus”
means the prospectus included in the Registration Statement (including, without limitation, a prospectus that includes any information
previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated
under the 1934 Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of any
portion of the Registrable Securities covered by the Registration Statement, and all other amendments and supplements to the Prospectus
including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference in such
Prospectus.

 

“Registrable
Securities” has the meaning set forth in Section 5(a).

 

“Registration
Statement” means each registration statement required to be filed under Article VI, including the Initial Registration
Statement, all Additional Registration Statements, and, in each case, the Prospectus, amendments and supplements to such registration
statement or Prospectus, including pre- and post-effective amendments, all exhibits thereto, and all material incorporated by reference
or deemed to be incorporated by reference in such registration statement.

 

“Required
Effectiveness Date” means the Initial Required Effectiveness Date and the Additional Required Effectiveness Date, as
applicable.

 

“Rule 144,”
“Rule 415,” and “Rule 424” means Rule 144, Rule 415 and Rule 424,
respectively, promulgated by the SEC pursuant to the Securities Act, as such Rules may be amended from time to time, or any similar
rule or regulation hereafter adopted by the SEC having substantially the same effect as such Rule.

 

“Securities”
means, collectively, the Common Stock, the Warrants and the Warrant Shares issued to the Purchasers pursuant to this Agreement.

 

“Trading
Day” means (a) any day on which the Common Stock is listed or quoted and traded on its primary Trading Market, or
(b) if the Common Stock is not then listed or quoted and traded on its primary Trading Market, then a day on which trading
of the Common Stock occurs on an Eligible Market, or (c) if the Common Stock is not listed or quoted as set forth in clauses (a)
or (b) hereof, any Business Day.

 

“Trading
Market” means any Eligible Market, or any national securities exchange, market or trading or quotation facility on which
the Common Stock is then listed or quoted.

 

“Transaction
Documents” means this Agreement, the schedules, exhibits and annexes attached hereto, and the Warrants.

 

    	24

     

    

 

6.          Conditions
to the Company’s Obligation to Sell. The obligation of the Company hereunder to issue the Offered Units to the Purchaser
at the Closing is subject to the satisfaction, at or before the Closing Date of each of the following conditions thereto, provided
that these conditions are for the Company’s sole benefit and may be waived by the Company at any time in its sole discretion:

 

a.           The
Purchaser shall have executed this Agreement and delivered the same to the Company.

 

b.           The
Purchaser shall have delivered the Purchase Price in accordance with Section 1(b) above.

 

c.           The
representations and warranties of the Purchaser shall be true and correct in all material respects as of the date when made and
as of the Closing Date as though made at that time (except for representations and warranties that speak as of a specific date),
and the Purchaser shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions
required by this Agreement to be performed, satisfied or complied with by the Purchaser at or prior to the Closing Date.

 

d.           No
litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated
or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority
over the matters contemplated hereby which prohibits the consummation of any of the transactions contemplated by this Agreement.

 

7.          Conditions
to The Purchaser’s Obligation to Purchase. The obligation of the Purchaser hereunder to pay the Purchase Price to the
Company at the Closing is subject to the satisfaction, at or before the Closing Date of each of the following conditions, provided
that these conditions are for the Purchaser’s sole benefit and may be waived by the Purchaser at any time in its sole discretion:

 

a.           The
Company shall have executed this Agreement and delivered the same to the Purchaser.

 

b.           The
representations and warranties of the Company shall be true and correct in all material respects as of the date when made and as
of the Closing Date as though made at such time (except for representations and warranties that speak as of a specific date), and
the Company shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions
required by this Agreement to be performed, satisfied or complied with by the Company at or prior to the Closing Date. The Purchaser
shall have received a certificate or certificates, executed by the chief executive officer of the Company, dated as of the Closing
Date, to the foregoing effect and as to such other matters as may be reasonably requested by the Purchaser.

 

    	25

     

    

 

c.           No
litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated
or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority
over the matters contemplated hereby which prohibits the consummation of any of the transactions contemplated by this Agreement.

 

d.           No
event shall have occurred which could reasonably be expected to have a Material Adverse Effect on the Company including but not
limited to a change in the 1934 Act reporting status of the Company or the failure of the Company to be timely in its 1934 Act
reporting obligations.

 

8.          Miscellaneous.

 

a.           Replacement
of Securities. If any certificate or instrument evidencing any securities is mutilated, lost, stolen or destroyed, the Company
shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof, or in lieu of and substitution
therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of such loss,
theft or destruction and customary and reasonable indemnity, if requested. The holder/applicant(s) for a new certificate or instrument
under such circumstances shall also pay any reasonable third-party costs associated with the issuance of such replacement securities.

 

b.           Governing
Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New York without regard
to principles of conflicts of laws. Any action brought by either party against the other concerning the transactions contemplated
by this Agreement shall be brought only in the state courts of New York or in the federal courts located in the state. The parties
to this Agreement hereby irrevocably waive any objection to jurisdiction and venue of any action instituted hereunder and shall
not assert any defense based on lack of jurisdiction or venue or based upon forum non conveniens. The Company and Purchaser
waive trial by jury. The prevailing party shall be entitled to recover from the other party its reasonable attorney's fees and
costs. In the event that any provision of this Agreement or any other agreement delivered in connection herewith is invalid or
unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it
may conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any such provision which may prove
invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision of any agreement.
Each party hereby irrevocably waives personal service of process and consents to process being served in any suit, action or proceeding
in connection with this Agreement or any other Transaction Document by mailing a copy thereof via registered or certified mail
or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement
and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any other manner permitted by law.

 

    	26

     

    

 

c.           Counterparts.
This Agreement may be executed by facsimile and in one or more counterparts, each of which shall be deemed an original but all
of which shall constitute one and the same agreement and shall become effective when counterparts have been signed by each party
and delivered to the other party.

 

d.           Headings.
The headings of this Agreement are for convenience of reference only and shall not form part of, or affect the interpretation of,
this Agreement.

 

e.           Severability.
In the event that any provision of this Agreement is invalid or unenforceable under any applicable statute or rule of law, then
such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform
with such statute or rule of law. Any provision hereof which may prove invalid or unenforceable under any law shall not affect
the validity or enforceability of any other provision hereof.

 

f.            Entire
Agreement; Amendments. This Agreement and the instruments referenced herein contain the entire understanding of the parties
with respect to the matters covered herein and therein and, except as specifically set forth herein or therein, neither the Company
nor the Purchaser makes any representation, warranty, covenant or undertaking with respect to such matters. No provision of this
Agreement may be waived or amended other than by an instrument in writing signed by the majority in interest of the Purchaser.

 

g.           Notices.
All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall be in writing
and, unless otherwise specified herein, shall be (i) hand delivered, (ii) deposited in the mail, registered or certified, return
receipt requested, postage prepaid, (iii) delivered by reputable national courier service with charges prepaid, or (iv) transmitted
by facsimile, addressed as set forth below or to such other address as such party shall have specified most recently by written
notice. Any notice or other communication required or permitted to be given hereunder shall be deemed effective (a) upon hand delivery
or delivery by facsimile, with accurate confirmation generated by the transmitting facsimile machine, at the address or number
designated below (if delivered on a business day during normal business hours where such notice is to be received), or the first
business day following such delivery (if delivered other than on a business day during normal business hours where such notice
is to be received) or (b) on the second business day following the date of mailing by express courier service, fully prepaid, addressed
to such address, or upon actual receipt of such mailing, whichever shall first occur. The addresses for such communications shall
be:

 

If to the
Company, to:

Arkados
Group, Inc.

Attn: Terrence
DeFranco

211 Warren
Street, Suite 320

Newark,
NJ 07103

 

    	27

     

    

 

With a copy
by fax only to (which copy shall not constitute notice):

 

Mark Crone

Corporate
Counsel

LKP Global
Law, LLP

1901 Avenue
of the Stars, Suite 480

Los Angeles,
CA 90067

Fax: (424) 239-1882

If to
the Purchaser:

To the address first set forth
in the Purchaser Signature and Subscription Page

of this Agreement

 

Each party
shall provide notice (in accordance with the requirements of this provision) to the other party of any change in address.

 

h.           Successors
and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and assigns.
Neither the Company nor the Purchaser shall assign this Agreement or any rights or obligations hereunder without the prior written
consent of the other.

 

i.            Third
Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective permitted successors
and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other person.

 

j.            Survival.
The representations and warranties of the Company and the agreements and covenants set forth in this Agreement shall survive the
closing hereunder notwithstanding any due diligence investigation conducted by or on behalf of the Purchaser. The Company agrees
to indemnify and hold harmless the Purchaser and all their officers, directors, employees and agents for loss or damage arising
as a result of or related to any breach or alleged breach by the Company of any of its representations, warranties and covenants
set forth in this Agreement or any of its covenants and obligations under this Agreement, including advancement of expenses as
they are incurred.

 

k.          Publicity.
The Company shall have the right to make, without prior approval, any SEC, OTC or FINRA filings, or any other public statements
with respect to the transactions contemplated hereby as is required by applicable law and regulations.

 

l.            Further
Assurances. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall
execute and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably request
in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated
hereby.

 

    	28

     

    

 

m.           No
Strict Construction. The language used in this Agreement will be deemed to be the language chosen by the parties to express
their mutual intent, and no rules of strict construction will be applied against any party.

 

n.           Remedies.
Each of the parties acknowledges that a breach by it of its obligations hereunder will cause immediate and irreparable harm to
the other party by vitiating the intent and purpose of the transaction contemplated hereby. Accordingly, each party acknowledges
that the remedy at law for a breach of its obligations under this Agreement will be inadequate and agrees, in the event of a breach
or threatened breach by a party of the provisions of this Agreement, that the other party shall be entitled, in addition to all
other available remedies at law or in equity, to an injunction or injunctions restraining, preventing or curing any breach of this
Agreement and to enforce specifically the terms and provisions hereof, without the necessity of showing economic loss and without
any bond or other security being required.

 

[REMAINDER OF PAGE LEFT INTENTIONALLY BLANK

SIGNATURE PAGES FOLLOW]

 

    	29

     

    

 

COMPANY SIGNATURE PAGE

TO ARKADOS SECURITIES PURCHASE AGREEMENT

 

IN WITNESS WHEREOF,
the undersigned Purchaser and the Company have caused this Securities Purchase Agreement to be duly executed as of the date
first written above.

 

	COMPANY:	 
	ARKADOS GROUP, INC.	 
	 	 	 
	By: 	/s/ Terrence DeFranco	 
	 	Terrence DeFranco	 
	 	President and Chief Executive Officer	 

 

[PURCHASER SIGNATURE AND SUBSCRIPTION PAGE
TO FOLLOW]

 

    	30

     

    

 

PURCHASER SIGNATURE AND SUBSCRIPTION PAGE

TO ARKADOS SECURITIES PURCHASE AGREEMENT

 

IN WITNESS WHEREOF,
each of the undersigned has caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.

 

Instructions: Please complete Section
1 through Section 4 below.

 

PURCHASER:

 

Section 1 

INVESTOR INFORMATION AND SUBSCRIPTION:

(choose one alternative by placing
“X” in box):

 

 ̈
(if entity):

 

Entity Name: _______________________________
(must be exact legal name)

 

By:_______________________________________

(Signature)

 

Name(Printed): _________________________________________

 

		Title:______________________________________	

 

Entity Taxpayer
Identification Number: ______________________________________

 

Email Address of Authorized contact:________________________________________________

 

	 ̈  (if individual):	 ̈  (if joint ownership with individual named):

 

	By:	 	 	By:	 
	 	(Signature)	 	 	(Signature)

 

	Name(Printed):	 	 	Name(Printed): 	 

 

	SSN:	 	 	SSN: 	 

 

    	31

     

    

 

Section 2:

ADDRESS, FACSIMILE, EMAIL FOR NOTICE (SECTION 7(G)) TO PURCHASER:

 

_______________________________________________________________________________________

 

_______________________________________________________________________________________

 

_______________________________________________________________________________________

 

Section 3:

ADDRESS FOR DELIVERY OF SECURITIES TO PURCHASER (if different
from Section 2 above):

 

______________________________________________________________________________________

 

______________________________________________________________________________________

 

______________________________________________________________________________________

 

Section 4:

AGGREGATE SUBSCRIPTION AMOUNT:

 

	Aggregate Number of Shares Purchased:	__________________
	 	 
	Aggregate Purchase Price:	$_________________

 

    	32

     

    

 

Annex A

 

CLOSING STATEMENT

 

All funds will be wired into the account
listed below. All funds will be disbursed in accordance with this Closing Statement.

 

	Disbursement Date:	upon receipt by the Company
	 	 

 

	I.   PURCHASE PRICE	 	 	 	 
	 	 	 	 	 	 	 
	 	 	Gross Proceeds to be Received	 	$	1,000,000.00	 
	 	 	 	 	 	 	 
	II.  DISBURSEMENTS	 	 	 	 
	 	 	 	 	 	 	 
	 	 	Fees	 	$	5,000.00	 
	 	 	 	 	 	 	 
	Total Amount Disbursed to Company:	 	$	 995,000.00	1

 

		1	does not include commissions of up to ten percent (10%)
of gross proceeds received from investors introduced by a broker dealer

 

WIRE INSTRUCTIONS:

Arkados Group, Inc.

211 Warren Street

Suite 320

Newark, NJ 07103

 

Bank Information:

Bank of America

1 Springfield Avenue

Newark, NJ 07102

 

Account Number: 381045612075

ABA/Routing Number: 026009593

Swift Code: BOFAUS3N (US dollars), BOFAUS6S (foreign currency)

 

    	33

     

    

 

Annex B

 

PLAN OF DISTRIBUTION

 

We may sell the securities offered through
this prospectus (1) to or through underwriters or dealers, (2) directly to purchasers, including our affiliates, (3) through
agents, or (4) through a combination of any of these methods. The securities may be distributed at a fixed price or prices,
which may be changed, market prices prevailing at the time of sale, prices related to the prevailing market prices, or negotiated
prices. The prospectus supplement will include the following information:

 

		•	the terms of the offering;

 

		•	the names of any underwriters or agents;

 

		•	the name or names of any managing underwriter or underwriters;

 

		•	the purchase price of the securities;

 

		•	the net proceeds from the sale of the securities;

 

		•	any delayed delivery arrangements;

 

		•	any underwriting discounts, commissions and other items
constituting underwriters’ compensation;

 

		•	any initial public offering price;

 

		•	any discounts or concessions allowed or reallowed or
paid to dealers; and

 

		•	any commissions paid to agents.

 

Sale Through Underwriters or Dealers

If underwriters are used in the sale, the
underwriters will acquire the securities for their own account, including through underwriting, purchase, security lending or repurchase
agreements with us. The underwriters may resell the securities from time to time in one or more transactions, including negotiated
transactions. Underwriters may sell the securities in order to facilitate transactions in any of our other securities (described
in this prospectus or otherwise), including other public or private transactions and short sales. Underwriters may offer securities
to the public either through underwriting syndicates represented by one or more managing underwriters or directly by one or more
firms acting as underwriters. Unless otherwise indicated in the prospectus supplement, the obligations of the underwriters to purchase
the securities will be subject to certain conditions, and the underwriters will be obligated to purchase all the offered securities
if they purchase any of them. The underwriters may change from time to time any initial public offering price and any discounts
or concessions allowed or reallowed or paid to dealers. The prospectus supplement will include the names of the principal underwriters
the respective amount of securities underwritten, the nature of the obligation of the underwriters to take the securities and the
nature of any material relationship between an underwriter and us.

 

    	34

     

    

 

If dealers are used in the sale of securities
offered through this prospectus, we will sell the securities to them as principals. They may then resell those securities to the
public at varying prices determined by the dealers at the time of resale. The prospectus supplement will include the names of the
dealers and the terms of the transaction.

 

Direct Sales and Sales Through Agents

We may sell the securities offered through
this prospectus directly. In this case, no underwriters or agents would be involved. Such securities may also be sold through agents
designated from time to time. The prospectus supplement will name any agent involved in the offer or sale of the offered securities
and will describe any commissions payable to the agent by us. Unless otherwise indicated in the prospectus supplement, any agent
will agree to use its reasonable best efforts to solicit purchases for the period of its appointment.

 

We may sell the securities directly to
institutional investors or others who may be deemed to be underwriters within the meaning of the Securities Act with respect to
any sale of those securities. The terms of any such sales will be described in the prospectus supplement.

 

At-the-Market Offerings 

To the extent that we make sales through
one or more underwriters or agents in at-the-market offerings, we will do so pursuant to the terms of a sales agency financing
agreement or other at-the-market offering arrangement between us, on the one hand, and the underwriters or agents, on the other.
If we engage in at-the-market sales pursuant to any such agreement, we will issue and sell our securities through one or more underwriters
or agents, which may act on an agency basis or a principal basis. During the term of any such agreement, we may sell securities
on a daily basis in exchange transactions or otherwise as we agree with the underwriters or agents. Any such agreement will provide
that any securities sold will be sold at prices related to the then prevailing market prices for our securities. Therefore, exact
figures regarding proceeds that will be raised or commissions to be paid cannot be determined at this time. Pursuant to the terms
of the agreement, we may agree to sell, and the relevant underwriters or agents may agree to solicit offers to purchase blocks
of our common stock or other securities. The terms of any such agreement will be set forth in more detail in the applicable prospectus
or prospectus supplement.

 

Market Making, Stabilization and Other
Transactions 

Unless the applicable prospectus supplement
states otherwise, each series of offered securities will be a new issue and will have no established trading market. We may elect
to list any series of offered securities on an exchange. Any underwriters that we use in the sale of offered securities may make
a market in such securities, but may discontinue such market making at any time without notice. Therefore, we cannot assure you
that the securities will have a liquid trading market.

 

    	35

     

    

 

Any underwriter may also engage in stabilizing
transactions, syndicate covering transactions and penalty bids in accordance with Rule 104 under the Securities Exchange Act
of 1934, as amended. Stabilizing transactions involve bids to purchase the underlying security in the open market for the purpose
of pegging, fixing or maintaining the price of the securities. Syndicate covering transactions involve purchases of the securities
in the open market after the distribution has been completed in order to cover syndicate short positions.

 

Penalty bids permit the underwriters to
reclaim a selling concession from a syndicate member when the securities originally sold by the syndicate member are purchased
in a syndicate covering transaction to cover syndicate short positions. Stabilizing transactions, syndicate covering transactions
and penalty bids may cause the price of the securities to be higher than it would be in the absence of the transactions. The underwriters
may, if they commence these transactions, discontinue them at any time.

 

Derivative Transactions and Hedging

We, the underwriters or other agents may
engage in derivative transactions involving the securities. These derivatives may consist of short sale transactions and other
hedging activities. The underwriters or agents may acquire a long or short position in the securities, hold or resell securities
acquired and purchase options or futures on the securities and other derivative instruments with returns linked to or related to
changes in the price of the securities. In order to facilitate these derivative transactions, we may enter into security lending
or repurchase agreements with the underwriters or agents. The underwriters or agents may effect the derivative transactions through
sales of the securities to the public, including short sales, or by lending the securities in order to facilitate short sale transactions
by others. The underwriters or agents may also use the securities purchased or borrowed from us or others (or, in the case of derivatives,
securities received from us in settlement of those derivatives) to directly or indirectly settle sales of the securities or close
out any related open borrowings of the securities.

 

Electronic Auctions 

We may also make sales through the Internet
or through other electronic means. Since we may from time to time elect to offer securities directly to the public, with or without
the involvement of agents, underwriters or dealers, utilizing the Internet or other forms of electronic bidding or ordering systems
for the pricing and allocation of such securities, you should pay particular attention to the description of that system we will
provide in a prospectus supplement.

 

Such electronic system may allow bidders
to directly participate, through electronic access to an auction site, by submitting conditional offers to buy that are subject
to acceptance by us, and which may directly affect the price or other terms and conditions at which such securities are sold. These
bidding or ordering systems may present to each bidder, on a so-called “real-time” basis, relevant information to assist
in making a bid, such as the clearing spread at which the offering would be sold, based on the bids submitted, and whether a bidder’s
individual bids would be accepted, prorated or rejected. For example, in the case of a debt security, the clearing spread could
be indicated as a number of “basis points” above an index treasury note. Of course, many pricing methods can and may
also be used.

 

Upon completion of such an electronic auction
process, securities will be allocated based on prices bid, terms of bid or other factors. The final offering price at which securities
would be sold and the allocation of securities among bidders would be based in whole or in part on the results of the Internet
or other electronic bidding process or auction.

 

    	36

     

    

 

General Information 

Agents, underwriters, and dealers may be
entitled, under agreements entered into with us, to indemnification by us against certain liabilities, including liabilities under
the Securities Act.

 

    	37

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00269-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00269-of-00352.parquet"}]]